SipNose Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

SipNose General Information

Description

Developer of intranasal drug delivery devices designed to improve drug efficacy, patient compliance, and safety through non-invasive nose-to-brain drug delivery. The company offers single-use, multi-dose, and reusable devices tailored for daily or emergency use in clinical or home settings, enabling patients to administer medications efficiently with consistent dosing, improving treatment outcomes without invasive procedures.

Contact Information

Website
www.sipnose.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly Angel backed
Corporate Office
  • 13 Hayetzira Street
  • Yokneam 2066720
  • Israel
+972
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Therapeutic Devices
Parent Company
Corporate Office
  • 13 Hayetzira Street
  • Yokneam 2066720
  • Israel
+972

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SipNose Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 16-Sep-2024 Completed Generating Revenue
1. Angel (individual) Completed Generating Revenue
To view SipNose’s complete valuation and funding history, request access »

SipNose Patents

SipNose Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022101850-A1 Devices and methods for delivering a substance to a body cavity Inactive 14-Nov-2020
WO-2022101851-A1 Devices and methods for delivering a substance to a body cavity Inactive 14-Nov-2020
WO-2021260631-A1 Devices and methods for delivering a substance to a body cavity utilizing blow-fill-seal technology Inactive 25-Jun-2020
WO-2021245605-A1 Drug delivery devices and methods for administering substances to a body cavity by heterogenous aerosolization for treatment of binge-eating disorders and/or obesity Inactive 04-Jun-2020
WO-2021176402-A1 Devices and methods for delivering a substance to a body cavity Inactive 05-Mar-2020 A61M11/007
To view SipNose’s complete patent history, request access »

SipNose Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
Angel (individual) Minority
Angel (individual) Minority
To view SipNose’s complete investors history, request access »

SipNose FAQs

  • When was SipNose founded?

    SipNose was founded in 2011.

  • Where is SipNose headquartered?

    SipNose is headquartered in Yokneam, Israel.

  • What industry is SipNose in?

    SipNose’s primary industry is Drug Delivery.

  • Is SipNose a private or public company?

    SipNose is a Private company.

  • What is SipNose’s current revenue?

    The current revenue for SipNose is .

  • Who are SipNose’s investors?

    , , and have invested in SipNose.

  • When was SipNose acquired?

    SipNose was acquired on 16-Sep-2024.

  • Who acquired SipNose?

    SipNose was acquired by AptarGroup.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process